首页 | 本学科首页   官方微博 | 高级检索  
检索        

~(131)I SPECT/CT断层融合显像在分化型甲状腺癌中的临床价值
引用本文:栾兆生,周雯,唐为国,李艳玲,王建新,王其国,和燕.~(131)I SPECT/CT断层融合显像在分化型甲状腺癌中的临床价值[J].中国医学影像学杂志,2010,18(1):86-88.
作者姓名:栾兆生  周雯  唐为国  李艳玲  王建新  王其国  和燕
作者单位:解放军第88医院核医学科,山东泰安,271000
摘    要:目的:探讨131^I SPECT/CT断层融合显像在分化型甲状腺癌诊治检测中的临床价值。材料和方法:选择术后病理证实并接受131^I治疗的分化型甲状腺癌(DTC)患者97例,行131^I全身扫描(131^I-WBS)和病灶部位的SPECT断层加同机CT融合显像。将131^I-WBS与断层融合图像进行对比分析,探讨断层融合显像的特点与临床价值。结果:97例分化型甲癌患者共进行131^I-WBS251次,断层融合显像102次,每例患者至少行一次断层融合显像。与131^I-WBS比较,断层融合显像有如下特点:能够获得直观的断层融合显像和三维立体图像;②发现更多的病灶;③更准确地判断病变部位;④定位CT可以发现无摄碘功能的病灶;⑤鉴别病灶和生理显影或污染。结论:131^I SPECT/CT断层融合显像可以直观病变立体形态、大小、摄取程度和毗邻关系,在鉴别病灶与生理显像或污染、确定病灶是否有摄碘功能方面有重要价值,是131^I-WBS的重要补充。

关 键 词:甲状腺肿瘤碘放射性同位素  体层摄影术  发射型计算机  单光子  131^I全身扫描  131^I断层融合显像  SPECT/CT

Clinical Value of ~(131)I SPECT/CT Fusion Imaging in Differentiated Thyroid Cancer
Luan Zhaosheng,Zhou Wen,Tang Weiguo,Li Yanling,Wang Jianxin,Wang Qiguo,He Yan.Clinical Value of ~(131)I SPECT/CT Fusion Imaging in Differentiated Thyroid Cancer[J].Chinese Journal of Medical Imaging,2010,18(1):86-88.
Authors:Luan Zhaosheng  Zhou Wen  Tang Weiguo  Li Yanling  Wang Jianxin  Wang Qiguo  He Yan
Institution:Luan,Zhaosheng Zhou,Wen Tang,Weiguo Li,Yanling Wang,Jianxin Wang,Qiguo He,Yan Department of Nuclear Medicine,Chinese PLA 88 Hospital,Taian 271000
Abstract:Purpose The clinical advantages of 131I SPECT/CT fusion imaging over planar imaging of differentiated thyroid cancer(DTC)were studied.Materials and Methods 97 DTC accepting 131I therapy after thyroid surgery underwent planar 131I whole-body scan(WBS)and SPECT/CT fusion imaging.The diagnostic performance of 131I-WBS and SPECT/CT were comparatively analyzed.Results The patients had totally 251131I-WBS and 102 SPECT/CT imaging.In comparison to WBS,SPECT/CT fusion images were proven of a few advantages,such as:...
Keywords:SPECT/CT  thyroid neoplasms  iodine radioisotapes  tomography  emission-computed  single-photon
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号